• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.60% Nasdaq Down0.39%

    More On ONCY

    Quotes

    Charts

    News & Info

    Company

    • Profile
    • Key Statistics
    • SEC Filings
    • Competitors
    • Industry
    • Components

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Oncolytics Biotech Inc. (ONCY)

    -NasdaqCM
    0.33 0.00(0.00%) Nov 4, 4:00PM EST
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):N/A
    Mean Recommendation (last week):N/A
    Change:N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:N/A
    Median Target:N/A
    High Target:N/A
    Low Target:N/A
    No. of Brokers:N/A

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Sep 17, 2014StifelDowngradeBuyHold
    Aug 30, 2012Stifel NicolausInitiated Buy
    May 17, 2011OppenheimerInitiated Perform
    Apr 13, 2011WedbushInitiated Outperform
    Dec 22, 2009Rodman & RenshawDowngradeMkt OutperformMkt Perform
    Oct 16, 2008Merriman Curhan FordInitiated Buy
    Jan 15, 2008Rodman & RenshawInitiated Mkt Outperform
    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy
    Buy
    Hold
    Underperform
    Sell

    Data provided by Thomson/First Call


    Currency in USD.